Conference Proceedings
Tubular protection with empagliflozin treatment in subjects with type 2 diabetes and cardiovascular disease: a sub-analysis of the EMPA-HEART CardioLink-6 trial
E Opingari, S Verma, CD Mazer, KA Connelly, AT Yan, F Zuo, T Mason, B Chowdhury, Y Pan, A Quan, H Teoh, LA Leiter, B Zinman, DZI Cherney, RE Gilbert
DIABETOLOGIA | SPRINGER | Published : 2019
Grants
Funding Acknowledgements
Supported by: Boehringer Ingelheim